Blog

by Vineti | August 11, 2020
Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions

by Amy DuRoss | May 28, 2020
Cancer, serious genetic disorders, and other pressing health conditions never stop. Neither does cell and gene therapy. And that’s great news!

by Heidi Hagen and Christophe Suchet | April 2, 2020
The COVID-19 pandemic presents all of us with a dynamic, disruptive challenge unlike anything most of us have experienced in our lifetime. As we publish this post, we very much hope that all of you are safe and healthy.

by Heidi Hagen and Subbu Viswanathan | March 18, 2020
This post is the final post in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…

by Heidi Hagen and Subbu Viswanathan | March 11, 2020
This post is the fourth in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required